SoftBank is making a big bet on real estate tech. The Japanese telecom giant invested $450 million in Compass, a $2.2 billion real estate company shaking up the industry. Rob Lehman, Chief Revenue Officer at Compass, was with us to discuss what the deal means for the company.
With investments ranging from Uber to WeWork, SoftBank is one of the most influential investors in the tech community. Lehman explains that his company appealed to SoftBank because they recognized a technology gap in the real estate market that Compass was filling. He also points out Compass was an attractive investment because real estate is the largest asset globally.
With the new funding, Lehman says the company will focus on growth and continued investments in technology. When it comes to emerging technologies, Compass doesn't have plans for virtual reality. Instead, the company is more focused on artificial intelligence, says Lehman. In addition to technology, the new funding will go to breaking into tier one cities such as Atlanta and Phoenix, he adds.
YouTube will offer creators a way to rejoin the streaming platform if they were banned for violating COVID-19 and election misinformation policies that are no longer in effect.
Lukas Alpert of MarketWatch explores how networks, brands, and ad buyers absorb the shockwaves when late‑night show hosts are suddenly cut — and brought back.
A new poll finds U.S. adults are more likely than they were a year ago to think immigrants in the country legally benefit the economy. That comes as President Donald Trump's administration imposes new restrictions targeting legal pathways into the country. The Associated Press-NORC Center for Public Affairs Research survey finds Americans are more likely than they were in March 2024 to say it’s a “major benefit” that people who come to the U.S. legally contribute to the economy and help American companies get the expertise of skilled workers. At the same time, perceptions of illegal immigration haven’t shifted meaningfully. Americans still see fewer benefits from people who come to the U.S. illegally.
Shares of Tylenol maker Kenvue are bouncing back sharply before the opening bell a day after President Donald Trump promoted unproven and in some cases discredited ties between Tylenol, vaccines and autism. Trump told pregnant women not to use the painkiller around a dozen times during the White House news conference Monday. The drugmaker tumbled 7.5%. Shares have regained most of those losses early Tuesday in premarket trading.
